Richard Baum
MD
Professor
👥Biography 个人简介
Richard Baum at the THERANOSTICS Center is a pioneer in theranostics for neuroendocrine tumors, having developed and widely applied peptide receptor radionuclide therapy (PRRT) with lutetium-177 and yttrium-90 DOTATATE. His extensive clinical experience and research in PRRT, and his advocacy for theranostics as an approach to personalizing radiation therapy based on matched diagnostic imaging, has contributed to the establishment of PRRT as a standard neuroendocrine tumor treatment.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Richard Baum 的研究动态
Follow Richard Baum's research updates
留下邮箱，当我们发布与 Richard Baum（THERANOSTICS Center for Molecular Radiotherapy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment